To confirm whether the expression of PPARGC1A was indeed increased in TFE3 translocation-positive tRCC, the tumor tissues were stained with a PPARGC1A-specific antibody. The gene discussed is PPARGC1A; the disease is renal cell carcinoma associated with Xp11.2 translocations/TFE3 gene fusions.